Summary

Organization name

Profile

Auxilium Pharmaceuticals was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While they remain dedicated to this founding principle, Auxilium´s mission has expanded to include the development and marketing of novel treatment options for many of society´s unmet medical needs.

To support this mission of providing innovative solutions that promote healthy living, Auxilium is:

• providing healthcare specialists with quality products and practice support
• building on its development capability to deliver high-quality products for a range of unmet health needs
• pursuing licensing opportunities for additional products that complement its mission and development portfolio
• exploring business development and partnership opportunities

Auxilium´s core competency lies in the development and commercialization of therapeutics that address unmet medical needs. Given their corporate strategy of focusing resources outside of discovery activities, they rely on their business development group to serve this crucial function of sourcing innovation. In fact, Auxilium´s product and pipeline candidates have all been derived from licensing partnerships. Furthermore, collaborations enable Auxilium to maximize the value of its products once approved.

Auxilium seeks to in-partner products that treat serious problems that affect men and women as they age. Auxilium will consider various partnership arrangements such as: licensing, acquisition, and promotion. The company prefers marketed products or late-stage therapeutic candidates, but will consider earlier stage opportunities for differentiated molecules/products.

Indications of interest include:

• Benign prostatic hyperplasia
• Bladder cancer
• Erectile dysfunction
• Female sexual dysfunction
• Hypogonadism (TRT)
• Interstitial cystitis
• Male contraception
• Pain products
• Penile cancer
• Peyronie´s disease
• Premature ejaculation
• Prostate cancer
• Urinary antispasmodics
• Urinary incontinence / overactive bladder
• Urinary tract infections
• Other urologic or genitourinary abnormalities
• Endocrine-related disease states

URL

Your feedback

back